Galderma’s Global R&D Locations

Galderma’s five Research & Development centers are located in France, Sweden, the United States, Switzerland and Japan, and play a key role in discovering and developing innovative medical solutions for the global dermatology market, including products brought to both the United Kingdom and Republic of Ireland markets.

Discover more about Galderma's global Research & Development facilities below;

Sophia Antipolis, France

Galderma R&D SNC
Les Templiers - 2400, route des Colles - Sophia Antipolis, 06410 Biot - France


The world's largest R&D center specialised in dermatology:
Located in southeast France, dermatology company Galderma’s Sophia Antipolis facility is the largest laboratory in the world dedicated exclusively to dermatology. This state-of-the-art center is the birthplace of the adapalene molecule, the active ingredient of Differin, a topical treatment of acne. Five hundred scientists and support staff work at the center which hosts all of Galderma's in-house research, pre-clinical and core development (clinical, pharmaceutical and biometric) activities.
Since its opening at the end of 2006,this 19.300 sq meters facility accommodates our scientists with expertise ranging from genomics to proteomics, from high throughput technologies such as screening, chemistry and toxico-genomics to early pharmacokinetics.

 

Uppsala, Sweden

Q-Med AB - A Galderma Division
Seminariegatan 21 - visiting address: Fyrisvallsgatan 7 - 75228 Uppsala - Sweden

One of Galderma's international sites in Uppsala, Sweden is the Global Aesthetic Center of Excellence with nearly 400 employees as well as world-class research and manufacturing. The site is responsible for innovation, development, manufacturing and strategic brand management for aesthetic and corrective treatments. The majority of the products in the Galderma aesthetic & corrective portfolio produced at this site are based on the dermatology company’s patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid.

80 employees at the site are dedicated to Research & Development with a state-of-the-art expertise in understanding and modifying hyaluronic acid.

 

Princeton, USA

Galderma R&D Inc.
5 Cedar Brook Drive, suite 1 - Cranbury, NJ 08512 - USA


Located in New Jersey, the Princeton center is focused on clinical development projects with the primary objective of obtaining registration of Galderma's dermatology solutions and products in the US and Canada.

Clinical studies directed by this site are conducted under international clinical guidelines and are often used to support regulatory submissions for Galderma’s products around the world.

 

Tokyo, Japan

Galderma KK
Shinjuku Grand Tower, 34F
8-17-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-6134 -Japan

 

The R&D team in Tokyo is entirely devoted to the development and registration of new products for the Japanese market, the second largest dermatology market in the world.

 

Egerkingen, Switzerland

Galderma Spirig
Spirig Pharma AG
Froschackerstrasse 6
4622 Egerkingen – Switzerland

The R&D Self-medication unit in Egerkingen develops new products and maintains marketed products for all key self-medication brands. Research, development and core competences focusing on skin barrier function impairment, as well as sun protection are provided by a team of formulation specialists, clinicians, preclinical experts and project managers.

Galderma’s Self-medication business, one of its manufacturing plants and its Swiss affiliate are also situated in Egerkingen.

Discover more about Galderma, an international dermatology company.

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world

Read

Video

We are committed

See all videos